Overview
Marking 19 Years of QPPV Collaboration, Insight, and Progress
Now in its 19th year, the DIA Global QPPV Forum continues to be the only conference designed by QPPVs, for QPPVs—uniting leaders, subject matter experts, and peers from around the world in a dedicated setting for open exchange, practical learning, and professional growth.
More than just a conference, the Forum serves as a trusted environment where QPPVs can engage in meaningful discussions, reflect on evolving responsibilities, and strengthen their understanding of the systems that support patient safety. It is a uniquely neutral space where company affiliations take a back seat, titles are set aside, and participants can speak candidly confident that what is shared in the room, stays in the room.
As we look ahead to the Forum’s 20th anniversary in 2026, this year holds added significance. It offers a valuable opportunity to shape the ongoing development of the QPPV role and address the real-world challenges pharmacovigilance professionals face every day—together.
Featured
Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV) ? You've come to the right site!
Program Committee
-
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Angela Van Der Salm, PhD, MSc Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Shahinaz Badr, PharmD Pharmacovigilance Consultant and PVQA Auditor - EMEA
Independent Consultant, United Arab Emirates -
Gemma Jimenez Sese Senior Director, Deputy EU QPPV
AstraZeneca, Spain -
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Ilaria Grisoni, MSc Executive Director, Head of EU/International PV & Global Risk Management and EEA
Gentium Srl, A Jazz Pharmaceuticals Company, Italy
Have an account?